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Abstract:
Whilst the evidence for the efficacy of treatment interventions for 
individuals with dual diagnosis has been developing in recent decades, 
little is known about individual perceptions and the personal benefits of 
attending integrated treatment programmes within this population 
group. 
A qualitative methodology, Interpretive Phenomenological Analysis, was 
used to investigate the experiences of individuals with a range of 
complex mental health and co-existing substance misuse problems who 
took part in a Psychoeducational Group (PEG) Programme. This 
comprised of social support and therapeutic peer group relationship 
facilitation. Semi structured interviews were undertaken with 15 service 
users who successfully participated in this treatment Programme. 
Findings identify the complexity of the therapeutic process and 
understanding of the treatment from the service users perspective. This 
included the importance forming meaningful therapeutic relationships as 
an influential factor in countering a range of distressing and incompatible 
environmental and situational stressors, such as self-regulatory control, 
self-awareness of a need for change and the importance of integrated 
treatment in reducing the sense of stigma and exclusion linked with 
using mental health services. 
The study findings support the use of integrated treatment programmes 
in mental health services with a dual diagnosis population group.   
 




1 Title: ‘The group was the only therapy which supported my needs, because it helped me feel normal and I 
2 was able to speak out with a voice’: A qualitative study of an integrated group treatment for dual 
3 diagnosis service users within a community mental health setting.

































































5 Whilst the evidence for the efficacy of treatment interventions for individuals with dual 
6 diagnosis has been developing in recent decades, little is known about individual perceptions and 
7 the personal benefits of attending integrated treatment programmes within this population group. 
8 A qualitative methodology, Interpretive Phenomenological Analysis, was used to investigate 
9 the experiences of individuals with a range of complex mental health and co-existing substance 
10 misuse problems who took part in a Psychoeducational Group (PEG) Programme. This 
11 comprised of social support and therapeutic peer group relationship facilitation. Semi structured 
12 interviews were undertaken with 15 service users who successfully participated in this treatment 
13 Programme. 
14 Findings identify the complexity of the therapeutic process and understanding of the treatment 
15 from the service users perspective. This included the importance forming meaningful therapeutic 
16 relationships as an influential factor in countering a range of distressing and incompatible 
17 environmental and situational stressors, such as self-regulatory control, self-awareness of a need 
18 for change and the importance of integrated treatment in reducing the sense of stigma and 
19 exclusion linked with using mental health services. 
20 The study findings support the use of integrated treatment programmes in mental health 
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33 The term dual diagnosis spans a diverse range of mental health and substance misuse problems 
34 that an individual can experience concurrently (NICE, 2016). The nature of, and relationship 
35 between both dimensions of problems vary and change over time, and can be manifest in poor 
36 engagement with treatment services, non-adherence to prescribed medication and worsening 
37 prognosis (Gobbart, 2013). Therefore, an understanding of the complexities of co-occurring 
38 conditions is critical for effective treatment (Barrowclough et al., 2010).
39 Substance misuse among psychiatric spectrum disorders is widespread (NICE, 2016), and 
40 current estimates in the United Kingdom (UK) suggest that a third of service users with serious 
41 mental illness have a substance misuse problem, and up to half of individuals with substance 
42 misuse have an active mental health problem (Public Health England, 2017). Furthermore, active 
43 substance misuse among individuals with a psychiatric disorder has been associated with 
44 significantly poorer outcomes, making treatment provision problematic and predictably lengthier 
45 (Parrish, 2014).
46 The treatment profiles of service users with dual diagnoses are not always straightforward or 
47 linear in nature. Similarly, treating each condition independently of each other by different 
48 service providers is challenging, since the two conditions are not mutually exclusive (Taylor and 
49 Kliewer, 2006). Nevertheless, irrespective of these complexities, an integrated multimodal 
50 treatment approach is considered efficacious  (Kay‐Lambkin et al., 2009). This approach enables 
51 health care professionals an opportunity to utilise a range of beneficial therapeutic approaches to 
52 enhance treatment outcome. These might include motivational enhancement therapy, cognitive 
53 behavioural therapy, relapse prevention and psychoeducation interventions (Cleary et al., 2008). 
































































54 Furthermore, research using an integrated approach has found valuable treatment outcomes for 
55 service users with dual disorders who completed psychotherapeutic group treatment 
56 programmes, e.g. reduced symptomatology, reduced substance misuse and increased adherence 
57 to treatment intervention (Gobbart, 2013, Chilton et al., 2018). Gobbart (2013) concluded that 
58 their treatment approach augmented participants’ existing resources and galvanised their sense of 
59 trust and hope within an integrated care pathway, thus enhancing their individual resilience and 
60 adherence to treatment.
61 Whilst integrated approaches that combine mental health and substance misuse treatment have 
62 been seen to be effective (Chilton et al., 2018, Gobbart, 2013); the accounts of service users 
63 receiving such treatment remains scarce. In response to this, the current study investigated 
64 service users experiences of an integrated, psychoeducational group (PEG) therapy, designed to 
65 treat individuals with mental health and substance use disorders within an integrated delivery 
66 system. Specific details of the programme have been presented elsewhere (Chilton et al., 2018) 
67 but in summary it was designed upon principles of best practice (NMC, 2018) to enhance mental 
68 well-being and concordance. To understand more about the individual experiences of this client 
69 group, Interpretive Phenomenological Analysis (Smith, 2011) with semi-structured interviews 
70 was used to explore subjective experiences and perceptions of the therapeutic process. 
71 Methods
72 The PEG treatment programme was developed as a partnership outreach project between local 
73 mental health and substance misuse service providers to enhance service delivery for dual 
74 diagnosis services users. The programme is based around psychoeducational, harm-reduction, 
75 motivational and goal setting techniques that were adapted from a recovery-based dual diagnosis 
































































76 treatment manual (Derry, 2008). The PEG therapy model aimed to increase participants’ capacity 
77 to change their pattern of substance misuse and provide relevant information concerning aspects 
78 of their mental and physical well-being. Treatment comprised of 10 weekly 2-hour sessions per 
79 group. The maximum size of each group was set at 12 participants’ to ensure that it was large 
80 enough to enable all involved to engage effectively (Morgan and Carson, 2009). Eight 
81 programmes were completed during the 18-month period of evaluation. Furthermore, the study 
82 received ethical approval by the regional National Health Service Ethics Committee (NHSEC) 
83 and host Mental Health Trust.
84 The overarching aim of the study was to explore the individual experiences of participants with 
85 dual-diagnosis undertaking a group treatment intervention. Nine male and six female participants 
86 were purposively recruited for the study. Eligibility to be invited to take part was based on a 
87 diagnostic assessment for serious mental illness as well as substance misuse related diagnoses. 
88 Participants were also required to be able to read and speak English to the level necessary for 
89 completion of informed consent procedures and to participate meaningfully in group discussions 
90 and completion of the programme.  Health care professionals responsible for the overall care of 
91 dual-diagnosis clients were requested to identify suitable participants who had completed the 
92 treatment programme, who t could be approached to participate in a pre-interview to discuss 
93 participation in the more in depth, semi-structured interviews. Individuals who undertook a pre-
94 interview were provided with all the necessary information concerning the study and any 
95 outstanding queries regarding the study clarified.  Table 1 provides an overview of the 15 
96 participants who took participated in this qualitative investigation.
97 Table 1 here.

































































99 Once consent to take part was provided, participants were offered the opportunity to conduct the 
100 interview in their own home or at a nominated mental health resource centre within their local 
101 community.  Semi-structured interviews were employed to allow the participant to communicate 
102 more freely about their experience of being involved in PEG therapy (Reid et al., 2005). An 
103 interview schedule aided the interview process which was developed based upon the aim of the 
104 investigation. Example questions from the schedule included ‘what are your thoughts about the                   
105 treatment programme?’; ‘can you tell me how you felt whilst you were participating?’ and ‘have 
106 you experienced what you expected?’ Interviews were recorded and transcribed, with computer 
107 assisted qualitative software N-Vivo-8 (Bazeley and Jackson, 2013) used to store the data and 
108 manage the analysis process. In accordance with Interpretive Phenomenological Analysis (Smith, 
109 2011), transparency of the analysis process was assured through XXXX. reflexivity. This was 
110 supported by the maintenance of a journal to record participant interview observation, overall 
111 impressions of the treatment process and aid the researcher to ‘bracket off’ (Smith, 2011) 
112 personal assumptions, beliefs and presuppositions during the entirety of the study period, a 
113 necessary position when employing interpretative phenomenology. Anonymity and 
114 confidentiality of participants was protected at all times with the use of pseudonyms.
115
116 Results
117 The properties of the themes reflected the duality of personal subjective experiences of living 
118 with dual diagnosis and the multidimensional properties of the therapeutic process. Themes are 
119 presented in Table 2 and described with quotations from the transcripts to provide service user’s 
































































120 lived experiences through their own voices.  Quotations are presented with the participant’s 
121 pseudonym and the line number from the interview transcript. 
122 Table 2 here.
123
124 Dual Relationship with Illness
125 This theme encompassed characteristics of bio-psychosocial distress, comprising of complex 
126 levels of symptomatology that limited an individuals’ personal recovery. The relationship that 
127 substance misuse had alongside distressing symptoms of mental health conditions was evident on 
128 a number of contextual levels. These included participants’ ability to use substances as a means 
129 of diminishing their subjective experience of symptomatic distress, or believing that chronic or 
130 sustained levels of substance misuse had additional benefits, such as improving personal and 
131 social well-being in the context of the peer group experience. Participants’ subjective 
132 experiences oscillated around issues of managing denial and the impact this behaviour had on 
133 developing and maintaining relationships alongside a sense of belonging. These relationships had 
134 a beneficial effect on social acceptance, comprised of coping with painful memories of childhood 
135 trauma. In turn these antecedents and underlying social reinforcing factors acted on participant’s 
136 internal locus of control (Lefcourt, 2014), and personal attributes of motivational behaviour 
137 (Miller and Rollnick, 2012); 
138 ‘Not being able to say no to drugs is a problem, as I thought drugs helped me cope with life, and 
139 hoping it would take the pain away’ (David).
































































140  The factors effecting individuals’ perception of their complex condition reflected the 
141 idiosyncratic nature of substance misuse and individuals’ ability to make salient choices 
142 regarding their dependency on drugs. There was a recognition that the process of self-medicating 
143 with particular substances, such as alcohol and cannabis, had a self-regulatory effect upon 
144 participants’ mental health condition, thus supporting the self-medication theory (Khantzian, 
145 1987).  The phenomena of self-medication became a conduit as a way coping with side effects 
146 associated with prescribed psychiatric medication treatments; 
147 ‘I have been self-medicating for years with alcohol and drugs. I have always had problems with 
148 dealing with my problems such as anxiety and depression, and it has made me really scared over 
149 the years. I don’t like the shakes from my prescribed tablets, but I do have cannabis and alcohol 
150 to help me cope with the difficulty times in my life, as my problems bring me down all the time’ 
151 (Alexi). 
152 Exposing these aspects of experiential knowledge provided participants’ with the ability to view 
153 causal mechanisms and consequences of individual behaviour as an organic and incremental 
154 process of change. Participants’ accumulated an array of negative experiences in relation to their 
155 co-morbid condition, often resulting in a variety of maladaptive developmental responses. 
156 However, participants attempted to make sense of their maladaptive behaviour and complex case 
157 histories; 
158 ‘Drinking is the thing that I use to help me with my bad experiences and anxiety over time. The 
159 way I feel has never stayed the same, it just depended on the bad circumstances which have 
160 affected me over the years at given points in time’ (Spencer). 
































































161 Participants’ ability to interact with their social environment was a crucial factor in 
162 acknowledging and redefining their dual disorder in the context of their dependent behavioural 
163 patterns.
164 Levels of knowledge
165 This theme revealed a number of gaps in participants’ level of knowledge of how to manage their 
166 substance misuse effectively. Participant’s reported, for example, stimulant drug use as a means 
167 to address symptoms of mood disturbance without taking into account the consequences of 
168 associated rebound effects. However, the short and long-term effects of substance misuse 
169 resulted in a range of unpleasant emotional and psychological experiences such as anxiety, 
170 exhaustion; problems with volition, motivation and paranoia. Participants described their limited 
171 understanding concerning the consequences of their substance misuse and the interactive effects 
172 of their prescribed medication; 
173 ‘I did not know that alcohol had such a massive depressing effect on my mental health, 
174 especially as I thought the prescribed antidepressant from my doctor was helping me cope with 
175 my mood’ (Gary). 
176 This dual conflict of independence versus dependence was common place and demonstrated a 
177 dichotomy between the needs of the individual and the treatment perspective; traditionally based 
178 on prescriptive models of practice (NICE, 2016).  Participants’ expressed a degree of uncertainty 
179 concerning the longitudinal negative effects of their substance misuse and described their 
180 ongoing relationship with drugs as a form of personal reassurance and affiliation with a familiar 
181 behaviour (Cassidy et al., 2013). This comprised of personal levels of attachment by participants’ 
182 via cyclical and reinforcing methods of substance misuse. Some described their ongoing 
































































183 relationship with substance misuse as if it were a co-dependent emotional attachment, 
184 dysfunctional in nature, often associated with the ebb and flow of the tide (Buchanan-Barker and 
185 Barker, 2008); 
186 ‘I think at times my drug use changed week on week and it is just like kicking the cat which stirs 
187 up so many emotions in a very unstable way. The group helped me make sense of some of these 
188 emotions’ (Emily).
189 ‘The group made sense because it combined useful information about mental health and 
190 substance misuse. It was done in a way that made me feel supported’ (Stacey).
191 Getting started on alcohol and drugs
192 This theme explained the complex factors associated with commencing substance misuse. 
193 Traumatic or stressful life events were commonly cited as a precursor to drug use, contributing to 
194 individuals becoming increasingly vulnerable and experiencing long-term comorbidity (Chartier 
195 et al., 2009). The repeated misuse of illicit substances in response to environmental stressors and 
196 increasing levels of vulnerability, revealed a pattern of escalating drug use; 
197 ‘There were a number of circumstances that contributed to my drinking behaviour. I started 
198 drinking at 12 and then I lost my brother in a car accident and things just got worse’ (David)
199  For some participants the description of trauma related to experiences in early childhood was 
200 related to a marked decline in their mental well-being and quality of life which was manifest in a 
201 variety of mental health symptoms and maladaptive addictive behaviours (Romme and Escher, 
202 2013); 
































































203 ‘I was always having strange dreams regarding my abusive childhood. It got to the stage when I 
204 was drinking heavily, and the voices became really loud and negative and I got worse mentally. 
205 But it got to the stage when the voices were just there all the time telling me I was to blame no 
206 matter what I did and this just made me drink even more’ (Greg;). 
207 The implication of such psychopathology was dependent on some participant’s individual 
208 circumstances and social learning experiences. Many participants’ started consuming drugs and 
209 alcohol at a young age, resulting in some participants escalating from occasional use to more 
210 problematic dependency and tolerance to stronger drugs (Zernig et al., 2013).  For many 
211 participants this engendered a sense of helplessness and hopelessness, typically reinforced by 
212 poor and dysfunctional social networks, often leading to chronic periods of social isolation, 
213 stigma and depersonalisation. 
214
215
216 Impact of Condition on Behaviour and Lifestyle 
217 This theme explains participants’ aspiring to change aspects of their behaviour and lifestyle 
218 along with personal insight regarding the negative impact substance misuse played in their lives; 
219 ‘I was taking too many drugs which made me unhappy and paranoid. I did a lot of stupid things. 
220 I did not talk to many people, keeping myself to myself. I could just not understand why I was 
221 seeing people in the way I was, and hurting people who were close to me. My life did not make 
222 much sense and I struggled for years’ (Stuart).
































































223 For some participants’ there was a sense that something could be done to suspend or reverse the 
224 consequences of their maladaptive behaviour by acknowledging the beneficial component of 
225 peer support and engaging in the treatment process;
226 ‘My drug use was a big problem and I just wanted to get more control in my life and that is why 
227 I wanted to speak to other users in the group therapy who understood my problem. By being with 
228 others in the group who understood my problem it helped feel safe and think about my own 
229 situation and how it affected my relationship with my family and especially my daughter’ (Will).
230 However, treatment did not necessarily result in positive change or perceived social benefits. It 
231 was acknowledged that sometimes it can be difficult to socialise with others, being caught up in 
232 a duality of despair, often resulting in social isolation, dysfunctional relationships, and ongoing 
233 poor engagement with mental health services reinforced over many years (Drake et al., 2006).
234 Motivation to Change
235 This theme included a focus upon taking action to change behaviour. Change was supported by 
236 motivation, which manifested in individual actions orientated towards modifying maladaptive 
237 and harmful behaviours. However, it was clear that some participants were at different stages in 
238 their recovery journeys, with a sense of hopefulness being a central component to the treatment 
239 process (Bonney and Stickley, 2008)
240 ‘There is a huge link regarding my mental health and drug use. I have been thinking about 
241 changing my life around for a long time. Coming to the group allowed me to make a positive 
242 jump forward. But you need the right kind of help and the right kind of information to make 
243 meaningful changes’ (Stacey).
































































244 Some participants displayed a level of self-awareness and readiness to change that resonated in 
245 their experience of the treatment process. Consolidating and maintaining changes was an 
246 important consideration acknowledged by participants. This factor is relevant as stages of 
247 motivation often comprise of cyclical episodes of relapse and remission (Kazdin, 2009). 
248 Participants demonstrated elevated levels of motivation which often emerged after considerable 
249 self-reflection reinforcing individual’s ability to consolidate positive and meaningful change;
250 ‘I am more aware, because we talked about taking control in the group and looking back I think I 
251 was planning things in my life but I just was not aware of it. The ability to think positively about 
252 change with others in the group gave me the confidence to consider moving forward’ (Lara).
253 Many participants’ regardless of their level of motivation required meaningful and cohesive 
254 support. The level of self-perception concerning social support with other people with the same 
255 sort of problem encapsulated collective, not singular social intervention. Consequently, the 
256 process of motivation to change resulted in, and their constant struggle for, control of their 
257 condition;
258 ‘I was not sure about the group and how motivated I was to work with others in the group. I am 
259 still using drugs and will not stop, but it did make me think about the risks and harm in my life. 
260 Drug use is risky and many of my mates have died using drugs’ (Gary).
261 Struggle for Control of Treatment
262 This theme explored the myriad of challenges faced by participants’ in relation to their treatment 
263 and the level of autonomy they experienced as recipients of mental health service provision. 
264 Prescribed psychiatric medication management was referred to frequently, with a variety of 
































































265 views being stated concerning the efficacy of treatment. Causal mechanisms and poor standard 
266 treatment outcomes were frequently highlighted as primary reasons for participants’ continuing 
267 to use illicit substances. The medical model (Hirschkorn and Bourgeault, 2007) was also deemed 
268 limited in its prescriptive scope and level of effectiveness to deal with participants’ complex 
269 needs. Many participants’ experienced challenges in self-managing and self-regulating their 
270 prescribed psychiatric drug treatment;
271 ‘I am on prescribed medication from the doctor, but I still have problems with voices and many 
272 side-effects of the medication like twitches and muscle stiffness. I have used a bit of cannabis to 
273 help with some of the side-effects, but I have not told the consultant psychiatrist because he 
274 would not understand’ (Gary).
275
276 The struggle for control of the treatment process by participants was conceptualised as an 
277 ongoing dialogue with treatment services to reduce the perceived negative impact of specific 
278 treatments. All participants’ were being prescribed psychiatric medication as part of their 
279 ongoing mental health condition, and were expressed in association with attempting to self-
280 manage their prescribed medication and illicit substance misuse;
281 ‘The new mental health drug kind of helps my hearing voices, but it does make me very drowsy. 
282 When I have taken heroin and in the past many of my voices do go away but it can cause 
283 problems with my prescribed treatment. It can be a double bind at times’ (Tony).
284 Communication with Others
































































285 Some participants’ described the inclusive treatment process  as a means of amplifying a sense of 
286 humility and empathy (Barker and Buchanan-Barker, 2004). Thus enabling active engagement 
287 with other group members, directly placing responsibility for their interaction to change their 
288 behaviour within the sphere of their control;
289 ‘I think sharing experiences with others was really important. If you talk to people you can have 
290 a sort of conversation and you bond with them. It can give you a sense of belonging and feeling 
291 normal because they understand where you are coming from. I also think it is the help you get 
292 through communication with others that really counts’ (Kay).
293 Group members shared similar problems with each other, and were able to help one another, on 
294 the same level, i.e. peer to peer. Some participants recognised their own emotional state and that 
295 of others in the group, enabling them to value and validate fellow members within a process of 
296 reciprocity and reflect on the importance of past experiences.
297 ‘The group was the only therapy which supported my needs because it helped me feel normal 
298 and I was able to speak out with a voice’ (Margarete).
299 The interpersonal and cohesive structure of the group programme was directly linked to 
300 individual perception and a sense of belonging and needing to affiliate of members to a 
301 supportive treatment intervention that validated the individual and the collective experience. 
302 Participants’ stressed the importance of effective communication and connecting with others. 
303 However, for some the treatment process identifies some challenges in forming and maintaining 
304 meaningful social relationships, generally; 
































































305 ‘I have been blamed for my drug use ever since I was in my adolescence. You might say that I 
306 have deserved it. But it is just how my life has been which makes it difficult to connect’ (Jacob).
307 The level of personal distress and the importance of personal attributes, such as trust and 
308 honesty, were perceived as important when forming beneficial relationships within a social 
309 context (Link and Phelan, 2013).
310 Sense of Belonging
311 This theme reflected the essence of the therapeutic group intervention and the opportunity it 
312 provided for participants to interact successfully with other group members; reinforcing a sense 
313 of self-identity and belonging to the treatment intervention. Participation itself and appreciation 
314 of being accepted unconditionally by other group members, with similar co-occurring conditions, 
315 had a regulatory effect on their negative experiences. This in turn supported some individuals to 
316 externalise the maladaptive characteristics of their behaviour and contextual perspectives of the 
317 treatment process;
318 ‘I have been in and out of treatment for years being passed from one service to another. The 
319 group helped me work through my problems and I felt accepted and part of something 
320 worthwhile and I felt accepted and part of something whole’ (Stuart). 
321 Participants stated they valued the experience of social inclusion and participation in the 
322 decision-making process concerning their health care provision which contrasted with their 
323 pervading sense of social exclusion and perceived stigma from mental health services and 
324 society at large, which they had endured over many years;
































































325 ‘I have experienced a lot of negative attitudes by other people over many years, who have 
326 blamed me for things that were not my fault, often not knowing who I was as a person or taking 
327 the time to ask’ (Robert).
328 ‘Because we had similar problems and backgrounds in the group I felt more confident to express 
329 my-self and because we all had something wrong with us it kind of made us stronger in a strange 
330 way’ (Lara).
331
332 The findings of the study suggest that providing integrated treatment for mental health and 
333 substance misuse through the use of PEG therapy proved beneficial across both dimensions of 
334 problems presented by people with dual diagnosis. Importantly, participants’ reported finding the 
335 formation of meaningful therapeutic relationships within the group to be an important factor in 
336 their experiences. The idiosyncratic nature of these relationships has been characterised as a 
337 means of countering a range of distressing and incompatible environmental and situational 
338 stressors, such as poor levels of symptom control and social anxiety (Chaplin et al., 2008). The 
339 importance of developing a sense of balance and perspective by participants’ in PEG therapy was 
340 considered crucial to reducing participants’ situational stressors and negative social influences 
341 consistent with poor service fidelity, high levels of relapse, stigma and escalating levels of social 
342 neglect and conflict (Walker et al., 2013).
343 Participants’ reported finding the integration of treatment to be beneficial in reducing the sense 
344 of stigma and exclusion linked with using mental health services (Minkoff, 2013). Effective 
345 treatment plans need to address the role played by single treatment delivery systems, and the 
346 effective application of holistic treatment approaches need to be considered an important aspect 
































































347 of treatment for individuals with complex comorbid conditions (NICE, 2016). It is important to 
348 highlight that although the conclusions from this study cannot be generalised, the findings have 
349 provided important insights into the therapeutic process through the consideration of the complex 
350 interactions of service user experience and the curative dynamics of the treatment process.
351 The study had a number of limitations. For example, the term dual diagnosis is broad and non-
352 specific, and whilst it is used frequently to describe a service user group, it is of little value when 
353 tailoring individual care or treatment. There is a danger of contributing to the homogenising 
354 effect through the use of this label.  In terms of participants, the study was constrained by a 
355 possible a self-selection bias in the participant sample and the applied, in-practice nature of  the 
356 study design. 
357
358 Relevance to clinical practice
359 Integrated treatment for dual diagnosis, where the mental illness and the substance use disorder 
360 are treated simultaneously, is a developing approach in clinical care.  This study provides further 
361 insight into the efficacy of such approaches by providing qualitative findings to complement the 
362 existing, yet sparse, evidence base. Understanding the dynamics of these treatment approaches, 
363 such as the important role of social integration and the provision of a social network for 
364 discussions with similar others, are useful factors for health care professionals to consider in the 
365 future design and delivery of treatment for dual diagnosis.  
366
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Table 1 Participant Demographic Profile
Pseudonym Gender Age Dual Condition
Alexi F 50 Schizophrenia/alcohol use disorder
David M 32 Depression/alcohol use disorder
Emily F 46 Schizophrenia/alcohol use disorder
Gary M 50 Schizophrenia/alcohol use disorder
Greg M 48 Schizophrenia/alcohol use disorder
Jacob M 39 Schizophrenia/drug dependence syndrome
Kay F 57 Bi-polar disorder/alcohol use disorder
Lara F 47 Depression/drug/alcohol use disorder
Margaret F 56 Schizophrenia/alcohol use disorder
Robert M 65 Bi-Polar disorder/alcohol use disorder
Stacey F 40 Schizophrenia/alcohol use disorder
Stuart M 39 Schizophrenia/drug dependence syndrome
Spencer M 29 Schizophrenia/alcohol use disorder
Tony M 24 Mixed anxiety and depressive/alcohol use disorder
Will M 47 Mixed anxiety and depressive/alcohol use disorder






























































Table 2 Emergent themes produced from participants’ experiences of PEG therapy
Theme
Dual relationship with illness
Levels of knowledge
Getting started on alcohol and drugs
Impact of condition
Motivation to change
Struggle for control of treatment
Communication with others
Sense of belonging
































































1 Title: ‘The group was the only therapy which supported my needs, because it helped me feel normal and I 
2 was able to speak out with a voice’:: A qualitative study of an  An iintegrated group treatment approach 
3 for dual diagnosis service users within a community mental health setting.. A qualitative approach.

































































5 Whilst the evidence for the efficacy of treatment interventions for individuals with dual 
6 diagnosis has been developing in recent decades, little is known about individual perceptions and 
7 the personal benefits of attending integrated treatment programmes within this population group. 
8 A qualitative methodology, Interpretive Phenomenological Analysis, was used to investigate 
9 the experiences of individuals with a range of complex mental health and co-existing substance 
10 misuse problems who took part in a Psychoeducational Group (PEG) Programme. This 
11 comprised of social support and therapeutic peer group relationship facilitation. Semi structured 
12 interviews were undertaken with 15 service users who successfully participated in this treatment 
13 Programme. 
14 Findings identify the complexity of the therapeutic process and understanding of the treatment 
15 from the service users perspective. This included the importance forming meaningful therapeutic 
16 relationships as an influential factor in countering a range of distressing and incompatible 
17 environmental and situational stressors, such as self-regulatory control, self-awareness of a need 
18 for change and the importance of integrated treatment in reducing the sense of stigma and 
19 exclusion linked with using mental health services. 
20 The study findings support the use of integrated treatment programmes in mental health 




































































25 KeywordsDual Diagnosis, mental health, substance misuse, qualitative, service users, 
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33 The term dual diagnosis spans a diverse range of mental health and substance misuse problems 
34 that an individual can experience concurrently (NICE, 2016). The nature of, and relationship 
35 between both dimensions of problems vary and change over time, and can be manifest in poor 
36 engagement with treatment services, non-adherence to prescribed medication and worsening 
37 prognosis (Gobbart, 2013). Therefore, an understanding of the complexities of co-occurring 
38 conditions is critical for effective treatment (Barrowclough et al., 2010).
39 Substance misuse among psychiatric spectrum disorders is widespread (NICE, 2016), and 
40 current estimates in the United Kingdom (UK) suggest that a third of service users with serious 
41 mental illness have a substance misuse problem, and up to half of individuals with substance 
42 misuse have an active mental health problem (Public Health England, 2017). Furthermore, active 
43 substance misuse among individuals with a psychiatric disorder has been associated with 
44 significantly poorer outcomes, making treatment provision problematic and predictably lengthier 
45 (Parrish, 2014).
46 The treatment profiles of service users with dual diagnoses are not always straightforward or 
47 linear in nature. Similarly, treating each condition independently of each other by different 
48 service providers is challenging, since the two conditions are not mutually exclusive (Taylor and 
49 Kliewer, 2006). Nevertheless, irrespective of these complexities, an integrated multimodal 
50 treatment approach is considered efficacious  (Kay‐Lambkin et al., 2009). This approach enables 
51 health care professionals an opportunity to utilise a range of beneficial therapeutic approaches to 
52 enhance treatment outcome. These might include motivational enhancement therapy, cognitive 
53 behavioural therapy, relapse prevention and psychoeducation interventions (Cleary et al., 2008). 
































































54 Furthermore, research using an integrated approach has found valuable treatment outcomes for 
55 service users with dual disorders who completed psychotherapeutic group treatment 
56 programmes, e.g. reduced symptomatology, reduced substance misuse and increased adherence 
57 to treatment intervention (Gobbart, 2013, Chilton et al., 2018). Gobbart (2013) concluded that 
58 their treatment approach augmented participants’ existing resources and galvanised their sense of 
59 trust and hope within an integrated care pathway, thus enhancing their individual resilience and 
60 adherence to treatment.
61 Whilst integrated approaches that combine mental health and substance misuse treatment have 
62 been seen to be effective (Chilton et al., 2018, Gobbart, 2013); the accounts of service users 
63 receiving such treatment remains scarce. In response to this, the current study investigated 
64 service users experiences of an integrated, psychoeducational group (PEG) therapy, designed to 
65 treat individuals with mental health and substance use disorders within an integrated delivery 
66 system. Specific details of the programme have been presented elsewhere (Chilton et al., 2018) 
67 but in summary it was designed upon principles of best practice (NMC, 2018) to enhance mental 
68 well-being and concordance. To understand more about the individual experiences of this client 
69 group, Interpretive Phenomenological Analysis (Smith, 2011) with semi-structured interviews 
70 was used to explore subjective experiences and perceptions of the therapeutic process. 
71 Methods
72 The PEG treatment programme was developed as a partnership outreach project between local 
73 mental health and substance misuse service providers to enhance service delivery for dual 
74 diagnosis services users. The programme is based around psychoeducational, harm-reduction, 
75 motivational and goal setting techniques that were adapted from a recovery-based dual diagnosis 
































































76 treatment manual (Derry, 2008). The PEG therapy model aimed to increase participants’ capacity 
77 to change their pattern of substance misuse and provide relevant information concerning aspects 
78 of their mental and physical well-being. Treatment comprised of 10 weekly 2-hour sessions per 
79 group. The maximum size of each group was set at 12 participants’ to ensure that it was large 
80 enough to enable all involved to engage effectively (Morgan and Carson, 2009). Eight 
81 programmes were completed during the 18-month period of evaluation. Furthermore, the study 
82 received ethical approval by the regional National Health Service Ethics Committee (NHSEC) 
83 and host Mental Health Trust.
84 The overarching aim of the study was to explore the individual experiences of participants with 
85 dual-diagnosis undertaking a group treatment intervention. Nine male and six female participants 
86 were purposively recruited for the study. Eligibility to be invited to take part was based on a 
87 diagnostic assessment for serious mental illness as well as substance misuse related diagnoses. 
88 Participants were also required to be able to read and speak English to the level necessary for 
89 completion of informed consent procedures and to participate meaningfully in group discussions 
90 and completion of the programme.  Health care professionals responsible for the overall care of 
91 dual-diagnosis clients were requested to identify suitable participants who had completed the 
92 treatment programme, who t could be approached to participate in a pre-interview to discuss 
93 participation in the more in depth, semi-structured interviews. Individuals who undertook a pre-
94 interview were provided with all the necessary information concerning the study and any 
95 outstanding queries regarding the study clarified.  Table 1 provides an overview of the 15 
96 participants who took participated in this qualitative investigation.
97 Table 1 here.

































































99 Once consent to take part was provided, participants were offered the opportunity to conduct the 
100 interview in their own home or at a nominated mental health resource centre within their local 
101 community.  Semi-structured interviews were employed to allow the participant to communicate 
102 more freely about their experience of being involved in PEG therapy (Reid et al., 2005). An 
103 interview schedule aided the interview process which was developed based upon the aim of the 
104 investigation. Example questions from the schedule included ‘what are your thoughts about the                   
105 treatment programme?’; ‘can you tell me how you felt whilst you were participating?’ and ‘have 
106 you experienced what you expected?’ Interviews were recorded and transcribed, with computer 
107 assisted qualitative software N-Vivo-8 (Bazeley and Jackson, 2013) used to store the data and 
108 manage the analysis process. In accordance with Interpretive Phenomenological Analysis (Smith, 
109 2011), transparency of the analysis process was assured through XXXX. reflexivity. This was 
110 supported by the maintenance of a journal to record participant interview observation, overall 
111 impressions of the treatment process and aid the researcher to ‘bracket off’ (Smith, 2011) 
112 personal assumptions, beliefs and presuppositions during the entirety of the study period, a 
113 necessary position when employing interpretative phenomenology. Anonymity and 
114 confidentiality of participants was protected at all times with the use of pseudonyms.
115
116 Results
117 The properties of the themes reflected the duality of personal subjective experiences of living 
118 with dual diagnosis and the multidimensional properties of the therapeutic process. Themes are 
119 presented in Table 2 and described with quotations from the transcripts to provide service user’s 
































































120 lived experiences through their own voices.  Quotations are presented with the participant’s 
121 pseudonym and the line number from the interview transcript. 
122 Table 2 here.
123
124 Dual Relationship with Illness
125 This theme encompassed characteristics of bio-psychosocial distress, comprising of complex 
126 levels of symptomatology that limited an individuals’ personal recovery. The relationship that 
127 substance misuse had alongside distressing symptoms of mental health conditions was evident on 
128 a number of contextual levels. These included participants’ ability to use substances as a means 
129 of diminishing their subjective experience of symptomatic distress, or believing that chronic or 
130 sustained levels of substance misuse had additional benefits, such as improving personal and 
131 social well-being in the context of the peer group experience. Participants’ subjective 
132 experiences oscillated around issues of managing denial and the impact this behaviour had on 
133 developing and maintaining relationships alongside a sense of belonging. These relationships had 
134 a beneficial effect on social acceptance, comprised of coping with painful memories of childhood 
135 trauma. In turn these antecedents and underlying social reinforcing factors acted on participant’s 
136 internal locus of control (Lefcourt, 2014), and personal attributes of motivational behaviour 
137 (Miller and Rollnick, 2012); 
138 ‘Not being able to say no to drugs is a problem, as I thought drugs helped me cope with life, and 
139 hoping it would take the pain away’ (David).
































































140  The factors effecting individuals’ perception of their complex condition reflected the 
141 idiosyncratic nature of substance misuse and individuals’ ability to make salient choices 
142 regarding their dependency on drugs. There was a recognition that the process of self-medicating 
143 with particular substances, such as alcohol and cannabis, had a self-regulatory effect upon 
144 participants’ mental health condition, thus supporting the self-medication theory (Khantzian, 
145 1987).  The phenomena of self-medication became a conduit as a way coping with side effects 
146 associated with prescribed psychiatric medication treatments; 
147 ‘I have been self-medicating for years with alcohol and drugs. I have always had problems with 
148 dealing with my problems such as anxiety and depression, and it has made me really scared over 
149 the years. I don’t like the shakes from my prescribed tablets, but I do have cannabis and alcohol 
150 to help me cope with the difficulty times in my life, as my problems bring me down all the time’ 
151 (Alexi). 
152 Exposing these aspects of experiential knowledge provided participants’ with the ability to view 
153 causal mechanisms and consequences of individual behaviour as an organic and incremental 
154 process of change. Participants’ accumulated an array of negative experiences in relation to their 
155 co-morbid condition, often resulting in a variety of maladaptive developmental responses. 
156 However, participants attempted to make sense of their maladaptive behaviour and complex case 
157 histories; 
158 ‘Drinking is the thing that I use to help me with my bad experiences and anxiety over time. The 
159 way I feel has never stayed the same, it just depended on the bad circumstances which have 
160 affected me over the years at given points in time’ (Spencer). 
































































161 Participants’ ability to interact with their social environment was a crucial factor in 
162 acknowledging and redefining their dual disorder in the context of their dependent behavioural 
163 patterns.
164 Levels of knowledge
165 This theme revealed a number of gaps in participants’ level of knowledge of how to manage their 
166 substance misuse effectively. Participant’s reported, for example, stimulant drug use as a means 
167 to address symptoms of mood disturbance without taking into account the consequences of 
168 associated rebound effects. However, the short and long-term effects of substance misuse 
169 resulted in a range of unpleasant emotional and psychological experiences such as anxiety, 
170 exhaustion; problems with volition, motivation and paranoia. Participants described their limited 
171 understanding concerning the consequences of their substance misuse and the interactive effects 
172 of their prescribed medication; 
173 ‘I did not know that alcohol had such a massive depressing effect on my mental health, 
174 especially as I thought the prescribed antidepressant from my doctor was helping me cope with 
175 my mood’ (Gary). 
176 This dual conflict of independence versus dependence was common place and demonstrated a 
177 dichotomy between the needs of the individual and the treatment perspective; traditionally based 
178 on prescriptive models of practice (NICE, 2016).  Participants’ expressed a degree of uncertainty 
179 concerning the longitudinal negative effects of their substance misuse and described their 
180 ongoing relationship with drugs as a form of personal reassurance and affiliation with a familiar 
181 behaviour (Cassidy et al., 2013). This comprised of personal levels of attachment by participants’ 
182 via cyclical and reinforcing methods of substance misuse. Some described their ongoing 
































































183 relationship with substance misuse as if it were a co-dependent emotional attachment, 
184 dysfunctional in nature, often associated with the ebb and flow of the tide (Buchanan-Barker and 
185 Barker, 2008); 
186 ‘I think at times my drug use changed week on week and it is just like kicking the cat which stirs 
187 up so many emotions in a very unstable way. The group helped me make sense of some of these 
188 emotions’ (Emily).
189 ‘The group made sense because it combined useful information about mental health and 
190 substance misuse. It was done in a way that made me feel supported’ (Stacey).
191 Getting started on alcohol and drugs
192 This theme explained the complex factors associated with commencing substance misuse. 
193 Traumatic or stressful life events were commonly cited as a precursor to drug use, contributing to 
194 individuals becoming increasingly vulnerable and experiencing long-term comorbidity (Chartier 
195 et al., 2009). The repeated misuse of illicit substances in response to environmental stressors and 
196 increasing levels of vulnerability, revealed a pattern of escalating drug use; 
197 ‘There were a number of circumstances that contributed to my drinking behaviour. I started 
198 drinking at 12 and then I lost my brother in a car accident and things just got worse’ (David)
199  For some participants the description of trauma related to experiences in early childhood was 
200 related to a marked decline in their mental well-being and quality of life which was manifest in a 
201 variety of mental health symptoms and maladaptive addictive behaviours (Romme and Escher, 
202 2013); 
































































203 ‘I was always having strange dreams regarding my abusive childhood. It got to the stage when I 
204 was drinking heavily, and the voices became really loud and negative and I got worse mentally. 
205 But it got to the stage when the voices were just there all the time telling me I was to blame no 
206 matter what I did and this just made me drink even more’ (Greg;). 
207 The implication of such psychopathology was dependent on some participant’s individual 
208 circumstances and social learning experiences. Many participants’ started consuming drugs and 
209 alcohol at a young age, resulting in some participants escalating from occasional use to more 
210 problematic dependency and tolerance to stronger drugs (Zernig et al., 2013).  For many 
211 participants this engendered a sense of helplessness and hopelessness, typically reinforced by 
212 poor and dysfunctional social networks, often leading to chronic periods of social isolation, 
213 stigma and depersonalisation. 
214
215
216 Impact of Condition on Behaviour and Lifestyle 
217 This theme explains participants’ aspiring to change aspects of their behaviour and lifestyle 
218 along with personal insight regarding the negative impact substance misuse played in their lives; 
219 ‘I was taking too many drugs which made me unhappy and paranoid. I did a lot of stupid things. 
220 I did not talk to many people, keeping myself to myself. I could just not understand why I was 
221 seeing people in the way I was, and hurting people who were close to me. My life did not make 
222 much sense and I struggled for years’ (Stuart).
































































223 For some participants’ there was a sense that something could be done to suspend or reverse the 
224 consequences of their maladaptive behaviour by acknowledging the beneficial component of 
225 peer support and engaging in the treatment process;
226 ‘My drug use was a big problem and I just wanted to get more control in my life and that is why 
227 I wanted to speak to other users in the group therapy who understood my problem. By being with 
228 others in the group who understood my problem it helped feel safe and think about my own 
229 situation and how it affected my relationship with my family and especially my daughter’ (Will).
230 However, treatment did not necessarily result in positive change or perceived social benefits. It 
231 was acknowledged that sometimes it can be difficult to socialise with others, being caught up in 
232 a duality of despair, often resulting in social isolation, dysfunctional relationships, and ongoing 
233 poor engagement with mental health services reinforced over many years (Drake et al., 2006).
234 Motivation to Change
235 This theme included a focus upon taking action to change behaviour. Change was supported by 
236 motivation, which manifested in individual actions orientated towards modifying maladaptive 
237 and harmful behaviours. However, it was clear that some participants were at different stages in 
238 their recovery journeys, with a sense of hopefulness being a central component to the treatment 
239 process (Bonney and Stickley, 2008)
240 ‘There is a huge link regarding my mental health and drug use. I have been thinking about 
241 changing my life around for a long time. Coming to the group allowed me to make a positive 
242 jump forward. But you need the right kind of help and the right kind of information to make 
243 meaningful changes’ (Stacey).
































































244 Some participants displayed a level of self-awareness and readiness to change that resonated in 
245 their experience of the treatment process. Consolidating and maintaining changes was an 
246 important consideration acknowledged by participants. This factor is relevant as stages of 
247 motivation often comprise of cyclical episodes of relapse and remission (Kazdin, 2009). 
248 Participants demonstrated elevated levels of motivation which often emerged after considerable 
249 self-reflection reinforcing individual’s ability to consolidate positive and meaningful change;
250 ‘I am more aware, because we talked about taking control in the group and looking back I think I 
251 was planning things in my life but I just was not aware of it. The ability to think positively about 
252 change with others in the group gave me the confidence to consider moving forward’ (Lara).
253 Many participants’ regardless of their level of motivation required meaningful and cohesive 
254 support. The level of self-perception concerning social support with other people with the same 
255 sort of problem encapsulated collective, not singular social intervention. Consequently, the 
256 process of motivation to change resulted in, and their constant struggle for, control of their 
257 condition;
258 ‘I was not sure about the group and how motivated I was to work with others in the group. I am 
259 still using drugs and will not stop, but it did make me think about the risks and harm in my life. 
260 Drug use is risky and many of my mates have died using drugs’ (Gary).
261 Struggle for Control of Treatment
262 This theme explored the myriad of challenges faced by participants’ in relation to their treatment 
263 and the level of autonomy they experienced as recipients of mental health service provision. 
264 Prescribed psychiatric medication management was referred to frequently, with a variety of 
































































265 views being stated concerning the efficacy of treatment. Causal mechanisms and poor standard 
266 treatment outcomes were frequently highlighted as primary reasons for participants’ continuing 
267 to use illicit substances. The medical model (Hirschkorn and Bourgeault, 2007) was also deemed 
268 limited in its prescriptive scope and level of effectiveness to deal with participants’ complex 
269 needs. Many participants’ experienced challenges in self-managing and self-regulating their 
270 prescribed psychiatric drug treatment;
271 ‘I am on prescribed medication from the doctor, but I still have problems with voices and many 
272 side-effects of the medication like twitches and muscle stiffness. I have used a bit of cannabis to 
273 help with some of the side-effects, but I have not told the consultant psychiatrist because he 
274 would not understand’ (Gary).
275
276 The struggle for control of the treatment process by participants was conceptualised as an 
277 ongoing dialogue with treatment services to reduce the perceived negative impact of specific 
278 treatments. All participants’ were being prescribed psychiatric medication as part of their 
279 ongoing mental health condition, and were expressed in association with attempting to self-
280 manage their prescribed medication and illicit substance misuse;
281 ‘The new mental health drug kind of helps my hearing voices, but it does make me very drowsy. 
282 When I have taken heroin and in the past many of my voices do go away but it can cause 
283 problems with my prescribed treatment. It can be a double bind at times’ (Tony).
284 Communication with Others
































































285 Some participants’ described the inclusive treatment process  as a means of amplifying a sense of 
286 humility and empathy (Barker and Buchanan-Barker, 2004). Thus enabling active engagement 
287 with other group members, directly placing responsibility for their interaction to change their 
288 behaviour within the sphere of their control;
289 ‘I think sharing experiences with others was really important. If you talk to people you can have 
290 a sort of conversation and you bond with them. It can give you a sense of belonging and feeling 
291 normal because they understand where you are coming from. I also think it is the help you get 
292 through communication with others that really counts’ (Kay).
293 Group members shared similar problems with each other, and were able to help one another, on 
294 the same level, i.e. peer to peer. Some participants recognised their own emotional state and that 
295 of others in the group, enabling them to value and validate fellow members within a process of 
296 reciprocity and reflect on the importance of past experiences.
297 ‘The group was the only therapy which supported my needs because it helped me feel normal 
298 and I was able to speak out with a voice’ (Margarete).
299 The interpersonal and cohesive structure of the group programme was directly linked to 
300 individual perception and a sense of belonging and needing to affiliate of members to a 
301 supportive treatment intervention that validated the individual and the collective experience. 
302 Participants’ stressed the importance of effective communication and connecting with others. 
303 However, for some the treatment process identifies some challenges in forming and maintaining 
304 meaningful social relationships, generally; 
































































305 ‘I have been blamed for my drug use ever since I was in my adolescence. You might say that I 
306 have deserved it. But it is just how my life has been which makes it difficult to connect’ (Jacob).
307 The level of personal distress and the importance of personal attributes, such as trust and 
308 honesty, were perceived as important when forming beneficial relationships within a social 
309 context (Link and Phelan, 2013).
310 Sense of Belonging
311 This theme reflected the essence of the therapeutic group intervention and the opportunity it 
312 provided for participants to interact successfully with other group members; reinforcing a sense 
313 of self-identity and belonging to the treatment intervention. Participation itself and appreciation 
314 of being accepted unconditionally by other group members, with similar co-occurring conditions, 
315 had a regulatory effect on their negative experiences. This in turn supported some individuals to 
316 externalise the maladaptive characteristics of their behaviour and contextual perspectives of the 
317 treatment process;
318 ‘I have been in and out of treatment for years being passed from one service to another. The 
319 group helped me work through my problems and I felt accepted and part of something 
320 worthwhile and I felt accepted and part of something whole’ (Stuart). 
321 Participants stated they valued the experience of social inclusion and participation in the 
322 decision-making process concerning their health care provision which contrasted with their 
323 pervading sense of social exclusion and perceived stigma from mental health services and 
324 society at large, which they had endured over many years;
































































325 ‘I have experienced a lot of negative attitudes by other people over many years, who have 
326 blamed me for things that were not my fault, often not knowing who I was as a person or taking 
327 the time to ask’ (Robert).
328 ‘Because we had similar problems and backgrounds in the group I felt more confident to express 
329 my-self and because we all had something wrong with us it kind of made us stronger in a strange 
330 way’ (Lara).
331
332 The findings of the study suggest that providing integrated treatment for mental health and 
333 substance misuse through the use of PEG therapy proved beneficial across both dimensions of 
334 problems presented by people with dual diagnosis. Importantly, participants’ reported finding the 
335 formation of meaningful therapeutic relationships within the group to be an important factor in 
336 their experiences. The idiosyncratic nature of these relationships has been characterised as a 
337 means of countering a range of distressing and incompatible environmental and situational 
338 stressors, such as poor levels of symptom control and social anxiety (Chaplin et al., 2008). The 
339 importance of developing a sense of balance and perspective by participants’ in PEG therapy was 
340 considered crucial to reducing participants’ situational stressors and negative social influences 
341 consistent with poor service fidelity, high levels of relapse, stigma and escalating levels of social 
342 neglect and conflict (Walker et al., 2013).
343 Participants’ reported finding the integration of treatment to be beneficial in reducing the sense 
344 of stigma and exclusion linked with using mental health services (Minkoff, 2013). Effective 
345 treatment plans need to address the role played by single treatment delivery systems, and the 
346 effective application of holistic treatment approaches need to be considered an important aspect 
































































347 of treatment for individuals with complex comorbid conditions (NICE, 2016). It is important to 
348 highlight that although the conclusions from this study cannot be generalised, the findings have 
349 provided important insights into the therapeutic process through the consideration of the complex 
350 interactions of service user experience and the curative dynamics of the treatment process.
351 The study had a number of limitations. For example, the term dual diagnosis is broad and non-
352 specific, and whilst it is used frequently to describe a service user group, it is of little value when 
353 tailoring individual care or treatment. There is a danger of contributing to the homogenising 
354 effect through the use of this label.  In terms of participants, the study was constrained by a 
355 possible a self-selection bias in the participant sample and the applied, in-practice nature of  the 
356 study design. 
357
358 Relevance to clinical practice
359 Integrated treatment for dual diagnosis, where the mental illness and the substance use disorder 
360 are treated simultaneously, is a developing approach in clinical care.  This study provides further 
361 insight into the efficacy of such approaches by providing qualitative findings to complement the 
362 existing, yet sparse, evidence base. Understanding the dynamics of these treatment approaches, 
363 such as the important role of social integration and the provision of a social network for 
364 discussions with similar others, are useful factors for health care professionals to consider in the 
365 future design and delivery of treatment for dual diagnosis.  
366
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